EIP logo

Copyright © 2007-2024 European Immunogenicity Platform


Celerion, an early clinical research organization, has the experience and capacity to exceed your bioanalytical expectations from method development and validation through rapid sample analysis supporting studies from late discovery through preclinical and late stage clinical development. With over 40 years’ experience, laboratories in Zürich, Switzerland and Lincoln, Nebraska USA, combining state-of-the-art technology and scientific expertise to accelerate the drug development by rapidly delivering high-quality data for comprehensive immunogenicity assessments, pharmacokinetics and biomarkers.

For more information, please visit the Celerion website

Back to top